{
  "ticker": "CRL",
  "last_updated": "2026-02-09T09:09:26.761259",
  "retention_years": 3,
  "count": 7,
  "transactions": [
    {
      "id": 912,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2026-01-30",
      "transaction_shares": "9500",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "29974"
    },
    {
      "id": 913,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2026-01-30",
      "transaction_shares": "39031",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "268341"
    },
    {
      "id": 914,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2026-01-30",
      "transaction_shares": "4236",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16251"
    },
    {
      "id": 915,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2026-01-30",
      "transaction_shares": "5456",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "29172"
    },
    {
      "id": 916,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP, CAO, Interim CFO",
      "transaction_date": "2026-01-30",
      "transaction_shares": "1668",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "15128"
    },
    {
      "id": 917,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Mintz Mark",
      "reporting_owner_cik": "0002071546",
      "reporting_owner_position": "EVP, Chief Information Officer",
      "transaction_date": "2026-01-30",
      "transaction_shares": "1797",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8147"
    },
    {
      "id": 918,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2026-01-30",
      "transaction_shares": "5006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "27368"
    }
  ]
}